The Center for Technology Licensing (CTL) is Cornell University's technology transfer office. We manage technology for Cornell's Ithaca campus, Weill Cornell Medicine, Cornell Tech, and Cornell AgriTech in Geneva.

GenVec, Inc.

GenVec, Inc., is a biopharmaceutical company developing therapeutic drugs for cancer and vaccines for infectious diseases including HIV, malaria, foot-and-mouth disease, respiratory syncytial virus (RSV), HSV-2, and influenza.  GenVec was acquired by Intrexon on June 16, 2017.

Location: Gaithersburg, MD

Foundation Cornell Technology Licensed: 1993